www.g4media.ro/italia-risca-o-criza-de-canabis-med

Italy faces a potential medicinal cannabis supply crisis following the bankruptcy of Dutch company Bedrocan, a key supplier in Europe. This situation may impact patients relying on cannabis for chronic pain and severe illness symptoms. Bedrocan's two Dutch subsidiaries filed for bankruptcy in early October, having supplied medicinal cannabis for over two decades through a state-controlled distribution system. Italy's dependence on imports is evident, with only a small fraction of cannabis sourced domestically. The sole authorized producer in Italy cannot meet national demand, leading to concerns about future supply. Patient organizations are advocating for increased domestic production and private sector involvement to reduce reliance on imports.